Fenwick & West represented Vida Health, a virtual care company that combines a human-centric approach with technology to address chronic and co-occurring physical and behavioral health conditions, in its $25 million round of funding. The funding was led by Ally Bridge Group, participation from AME Cloud Ventures, NGP Capital, Aspect Ventures, Canvas Ventures, Webb Investment Network and Workday Ventures.
Vida provides personalized chronic condition management combined with health coaching and therapy through a mobile and online platform that supports individuals in managing and significantly improving conditions such as diabetes, hypertension, obesity, depression, anxiety, etc.
The company will use its new funds to meet the increased demand for remote care—particularly around mental health. Vida has reported an increase in demand for its service during the COVID-19 pandemic. Since early March, Vida has launched to more than 500,000 new end users, bringing the total number of people covered by its platform to over 1.4 million. More information can be obtained from the news announcement.
The Fenwick transaction team included corporate partners Michael Esquivel and Ryan Slunaker, technology transactions partner Stefano Quintini, and corporate associates Jennifer Cho and John Clancy.